Overview


A Duane syndrome is a condition that restricts horizontal eye movements. As a birth defect, it is present at birth. It is more common for people with this syndrome to have difficulty moving their eyes outward toward their ears. They can also have difficulty moving their eyes inward toward their nose due to this. When they attempt to move their eyes inward, their eyelids partially close and their eyeball retracts into the socket.t. In most cases, Duane syndrome affects only one eye. Additionally, some people develop vision loss in the affected eye, resulting in straying vision. However, most people do not experience any other symptoms. When the sixth cranial nerve is absent or damaged, Duane syndrome occurs. One of the muscles that moves the eye laterally is controlled by this nerve in the brain. During early pregnancy, when cranial nerves and ocular muscles are developing, the problem occurs during the third to sixth week. Occasionally, the sixth cranial nerve does not develop or does not function properly. It is unknown why females are more likely to develop Duane syndrome than males. It is also more common for the left eye to be affected than the right eye. Even though it can be inherited, it usually manifests as a new condition within a family. There are three types of Duane syndrome. Type I causes reduced ability to turn the affected eye(s) outward, type II causes reduced ability to turn the affected eye(s) inward, and type III is characterized by reduced ability to turn both eyes. Patients with type I of Duane syndrome will have a head turn towards the involved side and will appear esotropic (crossed-eyed) when looking straight ahead. Surgical treatment is not needed for most patients with Duane syndrome. Duane syndrome is treated surgically for one of four reasons: To reduce a significant deviation from straight ahead. A significant abnormal head position must be eliminated. Upshoots and downshoots should be eliminated. In order to eliminate disfiguring abnormal eyelid positions. Aims of treatment include restoring straight-ahead eye alignment, eliminating an abnormal head posture, and preventing amblyopia. It is not always necessary to perform eye muscle surgery. As the affected nerve and muscle cannot be restored, the other eye muscles are adjusted to compensate and align the eyes better. Research and improvements for producing cost-effective and efficient treatments are projected to boost the global Duane syndrome treatment market. A surge in healthcare spending, increased awareness of the Duane syndrome, and government support are expected to boost the market growth. Moreover, new product releases and an emphasis on improving knowledge of genetic disorders and uncommon illnesses are expected to propel the global Duane syndrome treatment market.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Duane Syndrome Treatment Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Duane Syndrome Treatment Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Quest Diagnostics Inc
  • Centogene N.V.
  • Invitae Corp
  • 3Billion Inc
  • ARUP Laboratories
  • Eurofins Scientific
  • Strand Life Sciences
  • Ambry Genetics
  • Perkin Elmer Inc
  • Macrogen
  • Baylor Genetics
  • Color Genomics Inc
  • Health Network Laboratories
  • Preventiongenetics
  • Progenity Inc
  • Coopersurgical Inc
  • Fulgent Genetics Inc
  • Myriad Genetics inc
  • Laboratory Corporation Of America Holdings
  • Opko Health Inc

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Type

  • Outward (Type I)
  • Inward (type II)
  • Both (Type III)

By Diagnosis

  • Ocular Examination
  • Cervical and Thoracic Examination
  • Palate Examination
  • Vertebrae Examination
  • Hands Examination
  • Hearing Test

By Treatment

  • Observation
  • Treatment of Amblyopia
  • Surgery

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Duane Syndrome Treatment Market By Type, By Diagnosis, By Treatment, By End User and By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Duane Syndrome Treatment Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Duane Syndrome Treatment Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Duane Syndrome Treatment Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Duane Syndrome Treatment Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Outward (Type I)
        2. Inward (type II)
        3. Both (Type III)

  • 8.   Duane Syndrome Treatment Market, By Diagnosis Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Ocular Examination
        2. Cervical and Thoracic Examination
        3. Palate Examination
        4. Vertebrae Examination
        5. Hands Examination
        6. Hearing Test

  • 9.   Duane Syndrome Treatment Market, By Treatment Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Observation
        2. Treatment of Amblyopia
        3. Surgery

  • 10.   Duane Syndrome Treatment Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Ambulatory Surgical Centers
        3. Others

  • 11.   North America Duane Syndrome Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Duane Syndrome Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Duane Syndrome Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Duane Syndrome Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Duane Syndrome Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Quest Diagnostics Inc
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Centogene N.V.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Invitae Corp
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. 3Billion Inc
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. ARUP Laboratories
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Eurofins Scientific
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Strand Life Sciences
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Ambry Genetics
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Perkin Elmer Inc
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Macrogen
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Baylor Genetics
         11.1. Company Overview
         11.2. Product Portfolio
         111.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Color Genomics Inc
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Health Network Laboratories
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. Preventiongenetics
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. Progenity Inc
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
        16. Coopersurgical Inc
         16.1. Company Overview
         16.2. Product Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview
        17. Fulgent Genetics Inc
         17.1. Company Overview
         17.2. Product Portfolio
         17.3. SWOT Analysis
         17.4. Financial Overview
         17.5. Strategic Overview
        18. Myriad Genetics inc
         18.1. Company Overview
         18.2. Product Portfolio
         18.3. SWOT Analysis
         18.4. Financial Overview
         18.5. Strategic Overview
        19. Laboratory Corporation Of America Holdings
         19.1. Company Overview
         19.2. Product Portfolio
         19.3. SWOT Analysis
         19.4. Financial Overview
         19.5. Strategic Overview
        20. Opko Health Inc
         20.1. Company Overview
         20.2. Product Portfolio
         20.3. SWOT Analysis
         20.4. Financial Overview
         20.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 19.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients